記事掲載：AstraZeneca社、一貫性のある解析ワークフローが実験の解釈を深める

Genetic Engineering & Biotechnology News
June 6, 2016

In this article, learn how AstraZeneca's use of Genedata Screener^® demonstrates how pharmaceutical R&D organizations can implement a process that empowers scientists to  understand and interpret research better, ultimately enabling cost-effective and innovative drug discovery.